Question 165 · LEK · Treatment
”Easy dosage, causing neither hypoglycemia (when used in monotherapy) nor weight gain; there are proofs of reducing the cardiovascular and death risks, as well as delaying diabetic nephropathy” - is a description of the advantages of:
- A. long-acting insulin analogues.
- B. metformin.
- C. incretin mimetics.
- D. sulfonylureas.
- E. sodium-glucose cotransporter 2 inhibitors, so-called gliflozins.
Hint
Look for an oral, fixed-dose class with proven cardiovascular, mortality and renal outcome benefits.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Internal medicine
- A 53-year-old female patient was admitted to the hospital because of headache worsening for the last few days, fever (38.8 Celsius), nausea. On…
- Which of the following is not a risk factor for chronic pancreatitis?
- Bone marrow aplasia is characterized by:
- Indicate the true statement on the treatment of first episode of mild pseudomembranous colitis:
- Please indicate the results of arterial blood gases measurement corresponding to the exacerbation of chronic hypercapnic respiratory failure:
- Which of the following concerning autosomal dominant polycystic kidney disease (ADPKD) is true?